Nov 25, 2025

  • Corporate

Personnel Changes

TOKYO, November 25, 2025 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced the following personnel changes, effective January 1, 2026.

[Details of Personnel Changes]

Directors

NameNew ResponsibilitiesCurrent Responsibilities
Hitoshi Iikura

Director, Executive Vice President Supervisory responsibility for Research, Translational Research, Clinical Development, Corporate Planning and ASPIRE Transformation
Head of Corporate Planning Dept.
In charge of ASPIRE Transformation Dept.

Director, Executive Vice President Supervisory responsibility for Research, Translational Research, Clinical Development and Special Mission for CVF
Head of Translational Research Div.

Executive Officers

NameNew ResponsibilitiesCurrent Responsibilities
Tsukasa Kusano

Executive Vice President
Supervisory responsibility for Project & Lifecycle Management
Head of Project & Lifecycle Management Unit

Executive Vice President
Supervisory responsibility for Project & Lifecycle Management and Partnering
Head of Project & Lifecycle Management Unit
In charge of Partnering Dept.

Kaori Ouchi

Executive Vice President
Supervisory responsibility for Quality & Regulatory Compliance, Pharmaceutical Technology and Manufacturing Technology

Executive Vice President
Supervisory responsibility for Risk Management, Compliance and Quality & Regulatory Compliance, Pharmaceutical Technology, Manufacturing Technology
In charge of Risk & Compliance Dept.
Head of Risk & Compliance Dept.

Norihisa Onozawa

Executive Vice President
Supervisory responsibility for Digital Transformation, Partnering and Special Mission for CVF
In charge of Partnering Dept.

Executive Vice President
Supervisory responsibility for Corporate Planning, ASPIRE Transformation and Digital Transformation
Head of Corporate Planning Dept.
In charge of ASPIRE Transformation Dept.

Shoko Kimijima

Executive Vice President
Supervisory responsibility for Legal, Intellectual Property, Risk Management and Compliance
In charge of Legal Dept., Intellectual Property Dept. and Risk & Compliance Dept.

Executive Vice President
Supervisory responsibility for Legal and Intellectual Property
In charge of Legal Dept. and Intellectual Property Dept.

Please see the PDF file about other personnel changes.

 

Contact:

  • For Media
  • Chugai Pharmaceutical Co., Ltd.
  • Media Relations Group, Corporate Communications Dept.,
  • Hideki Sato
  • Tel: +81-3-3273-0881
  • E-mail: pr@chugai-pharm.co.jp
  • For Investors
  • Chugai Pharmaceutical Co., Ltd.
  • Investor Relations Group, Corporate Communications Dept.,
  • Takayuki Sakurai
  • Tel: +81-3-3273-0554
  • E-mail: ir@chugai-pharm.co.jp